Advisory Board

Fauxsee Innovations, LLC has an excellent board of advisors with a diverse background in technology, medical devices, entrepreneurial start-ups and manufacturing. The advisory board works closely with Fauxsee management in setting overall company goals and strategies and with comprehensive business planning.

Dr. Robert J. CalcaterraManaging Director
Startup Partners International, LLC

Dr. Robert J. Calcaterra is currently a principal in StartUp Partners International that is involved in the start up, structuring, managing, and financing of very early stage companies. Between 2009 and now StartUp Partners International has successfully started, organized, and funded 12 companies. Dr. Calcaterra was acting CEO of one of these companies CardiaLen, Inc. where he serves on the board of directors. He also was on the Board of Directors of Galera Therapeutics LLC and currently is on the of Euclises Therapeutics LLC, SARmont LLC, and Moleculara Labs Inc. in Oklahoma City OK. He has also been involved in raising $35M for these companies.

He has also been an adjunct faculty member in the Biomedical Engineering Department at Washington University and also at the University of Colorado and Arizona State University. He consults for many public and private institutions including companies in Nebraska, Kentucky and Arkansas, the USDA, EPA, University of Nebraska Lincoln, University of Iowa Foundation, Chicago State University, University of North Dakota and City of Madison Wisconsin. These latter activities have been concerned primarily with incubator development, commercialization of technology, venture capital and an innovation campus strategic plan.

Dr. Calcaterra brought 19 years of experience in incubator management to his position as president and chief executive officer of Nidus Center for Scientific Enterprise until July 1, 2008. The Nidus Center nurtured 20 plant and life sciences start-up companies. The Nidus Center won two consecutive national awards (2005-06) for Incubator Client of the Year. The Nidus Center hosted the National Business Incubation Association International Annual meeting in 2006. During Dr. Calcaterra's tenure at the three incubators he managed he has been involved in the creation of over 50 companies, has raised well over $250M in equity financing and served on the boards of at least 40 of those companies. He was also primarily responsible for the creation in St. Louis of the BioGenerator (a $7.8M proof of concept venture fund) and the Arch Angel Network where he currently is President. The Arch Angels have invested over $30M in 32 companies since its inception in 2005.

Prior to the Nidus Center Dr. Calcaterra was president, founder and chief executive officer of the Arizona Technology Incubator (ATI) and the Boulder technology incubator (BTI). Under Dr. Calcaterra's leadership, ATI won three consecutive awards (1996-98) in the categories of Incubator Company of the Year, Incubator Innovation of the Year and Incubator Graduate Company. ATI hosted the NBIA International Annual meeting in 1998. BTI also won a NBIA National Incubator of the year award.

Previously, Dr. Calcaterra worked for numerous Fortune 500 companies. While with the Adolph Coors Company, he was Director of Research & Development, Licensing, and Quality Assurance where he managed as many as 325 people. He also formed eight technically-based businesses for Adolph Coors Company. Prior to his work at Adolph Coors, Dr. Calcaterra worked as Senior Research Engineer for long-range strategic planning and technology forecasting and assessments for Amoco Corporation. He was also a research engineer for Alcoa Corporation and Monsanto Company, where he began his career in 1965.

Dr. Calcaterra is well known for his civic work involving small-business related issues. In 1995 he was appointed by President Bill Clinton as a delegate to the White House Conference on Small Business. He has served on the board of directors of the National Business Incubation Association. He also has served and chaired the boards of as many as 20 state and local economic development organizations in Colorado, Arizona and Missouri.

Dr. Calcaterra did his graduate and undergraduate work in chemical engineering at the University of Nebraska at Lincoln with BS and MS degrees. He received his D.Sc. in chemical engineering from Washington University of St. Louis and later completed Harvard University's Industrial Research Institute Executive Management Seminar.

Jeffry SkibaChief Technology Officer
Vomaris Innovations

Jeffry Skiba was the original CEO, President & Founder and now current Vice President & CTO of Vomaris Innovations. Skiba has more than 24 years of experience in leading medical device development and commercialization of first-to-market concepts. Skiba is the inventor of the Procellera® Wound Dressing.

He was a founder and Manager of Technical Services at International Polymer Engineering in 1992. There, he was responsible for the research and development of expanded PTFE polymers and PTFE production methods.

From 1993 to 1998, Skiba was Vice President of Manufacturing and Engineering at Orthopedic BioSystems Inc., where he directed the formation of the Research and Development Department, Inventory Management, Regulatory Submissions and a world class quality system approved by ISO and products stamped with the CE Mark for orthopedic deep tissue implants and instrumentation. Smith & Nephew eventually acquired this company.

Between 1998 and 2004 Skiba was the Director of Manufacturing and Engineering at TriVascular, at that time a start up company, where he was involved in the development of a percutaneously delivered abdominal aortic aneurism repair endograft.

Skiba also founded JBS Bioengineering in 1999, where he served as President. Heading the design and development of surgical implants sector until 2004, he was responsible for the development of a urologic implant system for type 3 stress incontinence funded by a grant, authored by Skiba, from the Office of Chief Scientist in Israel. The device was granted FDA clearance and two patents, authored by Skiba. In addition, he developed a unique system for Eye Medication delivery.

In 2012, Skiba co-authored with CWI, Antibacterial Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Isolates & was presented at Uniformed Services University of the Health Sciences Research Days 2012 Conference in Bethesda, Maryland. In 2013, Skiba was invited to speak at the Fifth Annual CWI Scientific Advisory Board Conference for the Henry M. Jackson Foundation.

Skiba holds a BS in both Bio-Mechanical Engineering and Business Administration. He is named on over 21 patents Domestic and International related to cardiovascular, orthopedic, OB/GYN and treatment of biologic tissue.

Dr. Inder MakinPrincipal
MakeMedTechLLC

Dr. Inder Makin is Associate Professor at AT-Still University (Schools of Osteopathic Medicine – SOMA and Dentistry - ASDOH), Adjunct Professor Arizona State University (Bioengineering). Over the years, he has been an independent scientist and entrepreneur active in the area of Medical Technology Development, among others, Director of Scientific Development, Vomaris Innovations. He is a co-founder of Guided Therapy Systems, LLC, Ulthera, Inc. and Xthetix, Inc. (VP Clinical and Application Development up to March 2009). During the past 20+ years, Dr. Makin has been active in strategy development and implementation of medical device technology, spanning the spectrum from "lab-to-market." From 2004 – March 2009, he led development and implementation of the pre- clinical and clinical strategy supporting the Ulthera System for cosmetic ultrasound applications. Scientifically, he has been involved in the basic and applied research of energy-based medical device systems, ultrasound-tissue interaction, sound-bubble interaction and propagation of high-intensity ultrasound through tissue-like media.

During his assignments in academia and industry, Dr. Makin has developed bio-medical research programs at various institutes, taking concepts through feasibility, and evolving them into product embodiments, such as, catheter-based devices for intravascular thrombolysis (Univ. of Washington/EKOS), transdermal drug delivery devices (Ethicon Endo-Surgery/Janssen Research Foundation), non-invasive and intracorporeal tissue ablation devices (Ethicon Endo-Surgery/GTS, Inc.), and ultrasound based image-treat devices for facial tissue tightening (GTS/Ulthera). From 1997 – 2004, Dr. Makin was the Principal Investigator and Technical Lead at Ethicon Endo-Surgery, Inc. J&J, leading a world-class team of engineering scientists in the development of ultrasound energy-based tissue therapy systems and surgical devices for therapeutic applications. He has worked as a Research Engineer at University of Washington, Applied Physics Laboratory, Research Fellow at Swarthmore College and Thomas Jefferson University, Philadelphia, and Research Assistant at University of Texas at Austin. Between 1985 and 1989 Dr. Makin worked at Drägerwerk AG in Lübeck, Germany and Deutsches Elektronen - Synchrotron, Hamburg (DESY), both in the area of medical physics and instrumentation.

Dr. Makin is a recognized scientist in the field of medical instrumentation and technology, having published more than 20 scientific papers, has been invited as speaker, and chaired various national and international conferences, and has 20 allowed and issued patents (filed >50). He completed his medical training, MBBS (M.D. equivalent), at Jiwaji, University, India in 1985 and his engineering degree ("Diplom Ingenieur" in Biomedical Engineering) from Fachhochschule Hamburg, Germany in 1989. In 1994, Dr. Makin completed his Ph.D. in Biomedical Engineering from Univ. of Texas at Austin, with specialization in nonlinear and medical acoustics. He is also an accredited medical sonographer (RDMS).


Mark TaylorPresident and CEO
Southern Aluminum

Mark Taylor is President and CEO of Southern Aluminum located in Magnolia, Arkansas. Southern Aluminum employs over 160 people. Founded by Mark's father Mr. Charles Taylor, Southern Aluminum has been an innovator of lightweight folding tables for over 35 years. Most notably, Southern Aluminum created a paradigm shift within the hospitality market for linen-less meeting and banquet tables. Recognized for his business acumen, Mark was named 2013 Business Person of the Year.

Outside of Southern Aluminum, Mark actively demonstrates his leadership throughout the community of Magnolia as well as Columbia County. He currently sits on the board of Bancorp South. Mark has volunteered his time to the Boys & Girls Club of Magnolia as a coach, annual sponsor of various sports, and numerous fundraiser events. He has served as past president and board member of Magnolia Country Club and several of its associations. Mark is actively involved with multiple committees within his church including serving as an elder, as a chairperson of the Stewardship committee, Pastoral Search committee, and many other boards.

More Information

Board Expertise

  • medical technology
  • medical devices
  • business and technical management
  • manufacturing
  • entreprenurial startup companies

  • Free Dreamweaver Templates | Cheap Web Hosting | Small Business Web Hosting